New Treatment Option for Prophylaxis in Severe Haemophilia A
Emicizumab (brand name: Hemlibra) is a bi-specific antibody which binds to both activated FIX and FX and allows the coagulation cascade to continue, and the blood to clot, in the …
New Treatment Option for Prophylaxis in Severe Haemophilia A Read More »







